Cargando…
Quality of life, disease activity and preferences for administration routes in rheumatoid arthritis: a multicentre, prospective, observational study
OBJECTIVE: We aimed to evaluate quality of life (QoL), disease activity, compliance to treatment, patient and physician preferences for route of administration (RoA), status of health and pain in RA patients starting advanced treatments or needing a switch, and the factors associated with patient pr...
Autores principales: | Direskeneli, Haner, Karadag, Omer, Ates, Askin, Tufan, Abdurrahman, Inanc, Nevsun, Koca, Serdar S, Cetin, Gozde Y, Akar, Servet, Cinar, Muhammet, Yilmaz, Sedat, Yilmaz, Neslihan, Dalkilic, Ediz, Bes, Cemal, Yilmazer, Baris, Sahin, Ali, Ersözlü, Duygu, Tezcan, Mehmet E, Sen, Nesrin, Keser, Gokhan, Kalyoncu, Umut, Armagan, Berkan, Hacibedel, Basak, Helvacioglu, Kerem, Cesur, Teoman Y, Basibuyuk, Canberk S, Alkan, Serdar, Gunay, Levent Mert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486987/ https://www.ncbi.nlm.nih.gov/pubmed/36133962 http://dx.doi.org/10.1093/rap/rkac071 |
Ejemplares similares
-
Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib
por: Inanc, Nevsun, et al.
Publicado: (2023) -
A national, multicenter, secondary data use study evaluating efficacy and retention of first-line biologic treatment with tocilizumab in patients with rheumatoid arthritis in real-life setting: results from TURKBIO registry
por: Yazici, Ayten, et al.
Publicado: (2022) -
A real-life analysis of patients with rheumatologic diseases on biological treatments: Data from TURKBIO Registry
por: Önen, Fatoş, et al.
Publicado: (2022) -
The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database
por: Alpay Kanıtez, Nilüfer, et al.
Publicado: (2022) -
IFN-γ stimulated dental follicle mesenchymal stem cells regulate activated lymphocyte response in rheumatoid arthritis patients in vitro
por: ZIBANDEH, Noushin, et al.
Publicado: (2019)